Fact Pattern 46-1
Pharma Corporation makes and sells QualMed, the most prescribed name-brand blood pressure-lowering medication. Renew Drugs, Inc., has the potential to make a generic version of the same drug.
-Refer to Fact Pattern 46-1. A court would most likely rule that the agreement between Pharma and Renew is
A) a deal that neither restrains trade or harms competition.
B) a legal restraint of trade.
C) a per se violation of the Sherman Act.
D) subject to analysis under the rule of reason.

Question

Fact Pattern 46-1​
Pharma Corporation makes and sells QualMed, the most prescribed name-brand blood pressure-lowering medication. Renew Drugs, Inc., has the potential to make a generic version of the same drug.
-Refer to Fact Pattern 46-1. A court would most likely rule that the agreement between Pharma and Renew is​
A) ​a deal that neither restrains trade or harms competition.
B) ​a legal restraint of trade.
C) ​a per se violation of the Sherman Act.
D) ​subject to analysis under the rule of reason.

Quizplus · Accepted Answer

The court would likely subject the agreement between Pharma and Renew to analysis under the rule of reason. This is because it involves a potential restraint of trade and may harm competition, but it is not automatically illegal. The court would have to weigh the potential benefits and drawbacks of the agreement to determine whether or not it violates antitrust laws.

Fact Pattern 46-1​ Pharma Corporation Makes and Sells QualMed, the Most Prescribed Name-Brand

Fact Pattern 46-1 Pharma Corporation Makes and Sells QualMed, the Most Prescribed Name-Brand